Stockscreener 앱 받기
1.08
2.70%
-0.03
시간 외 거래:
1.10
0.02
+1.85%
Bionano Genomics Inc 주식(BNGO)의 최신 뉴스
Bionano Genomics Announces Date for Second Quarter 2026 Financial Results Conference Call and Webcast - Quiver Quantitative
Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026 - The Manila Times
Bionano's Q2 Results Webcast Will Stay Online for at Least 30 Days - Stock Titan
Bionano Genomics Inc (BNGO) Cash Flow - TradingKey
Bionano Genomics Inc (BNGO) Balance Sheet - TradingKey
BNGO|Bionano Genomics Inc|Price:1.110| - TradingKey
Bionano Genomics Inc (BNGO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bionano Genomics Inc (BNGO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bionano Genomics Inc|Price:1.110 - TradingKey
Bionano Genomics Inc (BNGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bionano Genomics Inc (BNGO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bionano Genomics, Inc. Revenue Breakdown – BMV:BNGO - TradingView
BNGO Q2'26 Earnings: revenue estimate is 7.48M USD - TradingView
Number of shareholders of Bionano Genomics, Inc. – GETTEX:2Y3 - TradingView
Precision Trading with Bionano Genomics Inc. (BNGO) Risk Zones - Stock Traders Daily
BNGO Q1 2026 Earnings: EPS Surprises to the Upside Amidst Revenue UncertaintyHealthcare Earnings Report - dars.gov.et
Nabsys selects first-ever chief medical officer - Providence Business News
BNGO Q1 2026 Earnings: EPS Surpasses Estimates, but Revenue Remains UnreportedEarnings Preview - DonanımHaber
Price to sales forward of Bionano Genomics, Inc. – NASDAQ:BNGO - TradingView
Bionano Genomics (BNGO) Edges Higher Amid Continued ConsolidationIceberg Order - dars.gov.et
BNGO Should I Buy - Intellectia AI
Bionano Genomics, Inc. (BNGO) reports Q1 loss, tops revenue estimates - MSN
Bionano Genomics, Inc. Actuals & Estimates (NASDAQ:BNGO) - TradingView
BNGO Forecast — Price Target — Prediction for 2027 - TradingView
Bionano Genomics, Inc. Announces Appointment of Alex Hastie to Chief Scientific Officer, Effective July 20, 2026 - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Bionano Genomics Names Alex Hastie Chief Scientific Officer - The Globe and Mail
Bionano Genomics appoints Alex Hastie as chief scientific officer - Investing.com UK
Bionano Genomics appoints Alex Hastie as chief scientific officer By Investing.com - Investing.com South Africa
Bionano Genomics Appoints Dr. Alex Hastie as Chief Scientific Officer to Drive Innovation in Optical Genome Mapping - Minichart
Bionano Genomics Appoints Alex Hastie as Chief Scientific Officer - Quiver Quantitative
Bionano appoints Alex Hastie as Chief Scientific Officer to lead global science strategy - TradingView
Bionano Announces Hiring of Chief Scientific Officer - marketscreener.com
Alex Hastie returns as Chief Scientific Officer at Bionano Genomics (NASDAQ: BNGO) - Stock Titan
Bionano brings back OGM pioneer to lead science strategy July 20 - Stock Titan
Bionano Genomics Inc (BNGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BNGO Q1 2026 Earnings: EPS Surprises to the Upside Amid Continued Operational ChallengesEPS Revision Trend - dars.gov.et
Bionano Genomics (BNGO) Slips 1.72% as Stock Tests Key Support LevelsFactor Momentum - DonanımHaber
Bionano Genomics (BNGO) Sees Significant Growth in Optical Genome Mapping Studies - GuruFocus
Bionano Genomics reports 67% increase in studies at genetics conference - Investing.com
Bionano Genomics reports 67% increase in studies at genetics conference By Investing.com - Investing.com Canada
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption - The Manila Times
Bionano’s genome-mapping studies jump to 35 at ESHG 2026 - Stock Titan
Bionano Genomics Inc (BNGO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bionano Genomics Inc (BNGO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bionano Genomics Inc (BNGO) Institutional Confidence - TradingKey
Bionano Genomics Inc (BNGO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bionano Genomics (BNGO) Slides Amid Light Volume, Testing Support at $1.10Dealer Positioning - dars.gov.et
Bionano Genomics Keeps Penny Stock Risk In Focus - Kalkine Media
Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders - The Manila Times
Infertility gene clues: 13 studies find hidden variants with Bionano mapping - Stock Titan
BNGO News | BIONANO GENOMICS INC (NASDAQ:BNGO) - ChartMill
Bionano Genomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Bionano Genomics (BNGO) upgraded to buy: What does it mean for the stock? - MSN
Bionano Genomics (BNGO) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
BioNano Genomics Announces Resignation of Chief Medical Officer - The Globe and Mail
0.62%
0.03%
자본화:
|
볼륨(24시간):